News about Biotechnology

Limula Secures USD 6.8 Million in Oversubscribed Seed Round

Limula has raised USD 6.8 million to take their solution for automating cell therapy manufacturing to the next stage of development.

Biotechnology | 22/05/2024 | By Aishwarya |  425

GVSAP Join Hands with Biocytogen to Accelerate Biopharmaceutical Innovation

GV Safety Assessment Platform (GVSAP) has forged a groundbreaking partnership with Biocytogen, a leader in industry-leading technologies that propel drug discovery.

Biotechnology | 20/05/2024 | By Aishwarya |  522

Siren Biotechnology and Catalent to Manufacture AAV Gene Therapies for Cancer

Siren Biotechnology has signed a strategic partnership with Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies.

Biotechnology | 18/05/2024 | By Aishwarya |  661

TriLink Signs Non-Exclusive License and Supply Agreement with Lonza

TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries.

Biotechnology | 02/05/2024 | By Aishwarya |  759

INTEGRA Biosciences Launches MAG and HEATMAG Modules for Magnetic Bead Purification

These innovative solutions allow researchers to streamline several processing steps in molecular biology and proteomics workflows for maximum lab throughput.

Biotechnology | 23/02/2024 | By Manvi |  544

ABL Medical Developing Anti-Microbial Blue Light Fiber Technology

ABL Medical has now demonstrated the potential for blue light fiber-optic technology to combat microbial infections.

Biotechnology | 10/02/2024 | By Manvi |  516

MicrofluidX Announces Joint Research Project with Immatics for Automated End-to-End Bioprocessing for TCR-T Therapies

MicrofluidX announces a joint research project with Immatics to combine Immatics’ manufacturing of TCR-T cells with MicrofluidX’s innovative new platform, the Cyto Engine™.

Biotechnology | 03/05/2023 | By Manvi |  843

Novartis to invest $300 M in biologics manufacturing and development operations

The company plans to establish a biologics hub at its Basel, Switzerland campus

Biotechnology | 14/09/2022 | By Sudeep Soparkar |  768

Astellas plans to open biotech campus in South San Francisco

Astellas will invest approximately $70 million to create the new state-of-the-art facility, which will provide lab and co-working spaces to accommodate future growth

Biotechnology | 22/07/2022 | By Sudeep Soparkar |  1299

Merck unveils microbiology application lab in Jigani, Bengaluru

Supports capability built-up in microbial quality control in Pharma, and biopharma industry Merck invests €200,000 in the infrastructure of the new lab at Jigani

Biotechnology | 21/07/2022 | By Sudeep Soparkar |  1220